Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Serum 25(OH) Vitamin D Levels in Pregnant Women with Coronavirus Disease 2019 (COVID-19): A Case-Control Study

Ferrer-Sánchez et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph19073965
Mar 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
ICU admission 82% Improvement Relative Risk Moderate/severe case 89% Case 63% Vitamin D  Ferrer-Sánchez et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 82 patients in Spain Fewer cases with higher vitamin D levels (p=0.01) c19early.org Ferrer-Sánchez et al., Int. J. Environ.., Mar 2022 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,800+ studies for 98 treatments. c19early.org
Retrospective 256 pregnant women, 82 with COVID-19 and 174 controls, showing significantly lower vitamin D levels for COVID-19 patients.
This is the 127th of 204 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 107,767,362 vigintillion).
risk of ICU admission, 81.8% lower, RR 0.18, p = 1.00, high D levels (≥20ng/mL) 0 of 9 (0.0%), low D levels (<20ng/mL) 4 of 73 (5.5%), NNT 18, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), excluded in exclusion analyses: unadjusted results with no group details.
risk of moderate/severe case, 88.7% lower, RR 0.11, p = 1.00, high D levels (≥20ng/mL) 0 of 9 (0.0%), low D levels (<20ng/mL) 7 of 73 (9.6%), NNT 10, relative risk is not 0 because of continuity correction due to zero events (with reciprocal of the contrasting arm), excluded in exclusion analyses: unadjusted results with no group details.
risk of case, 62.7% lower, OR 0.37, p = 0.01, cutoff 20ng/mL, adjusted per study, inverted to make OR<1 favor high D levels (≥20ng/mL), multivariable, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ferrer-Sánchez et al., 26 Mar 2022, retrospective, Spain, peer-reviewed, 7 authors.
This PaperVitamin DAll
Serum 25(OH) Vitamin D Levels in Pregnant Women with Coronavirus Disease 2019 (COVID-19): A Case-Control Study
Nazaret Ferrer-Sánchez, Marina Díaz-Goicoechea, Victoria Mayoral-Cesar, Silvia García-Solbas, Bruno José Nievas-Soriano, Tesifón Parrón-Carreño, Ana María Fernández-Alonso
International Journal of Environmental Research and Public Health, doi:10.3390/ijerph19073965
The physiological changes during pregnancy may increase the risk of complications in pregnant women with coronavirus disease 2019 (COVID-19). Vitamin D is a fat-soluble secosteroid hormone and its role in immunity is appears to be of particular importance in this recent pandemic. Nevertheless, there is little research about the role of vitamin D levels regarding COVID-19 in pregnant women to date. This study aimed to establish a relationship between serum 25-hydroxyvitamin D (25(OH)D) levels in pregnant women and COVID-19. A comparative case-control study was performed with a study population of 256 pregnant women (82 pregnant women with infection and 174 women in control group). Serum 25(OH)D levels were significantly lower in pregnant women with COVID-19 infection than in those without infection. In addition, 89% of COVID-19-positive pregnant women had 25(OH)D deficiency, while in the control group the percentage was 75.30%, finding statistically significant differences (ORa = 2.68; 95% CI 1.19-6.06; p = 0.01). Our results find a relationship between vitamin D deficiency in pregnant women and COVID-19 infection. This finding could be relevant for actual clinical practice. Thus, more research is needed in this field.
Institutional Review Board Statement: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of the Torrecardenas University Hospital (protocol code 2607-143/2020 and date of approval: 27 January 2021). Informed Consent Statement: Informed consent was obtained from all subjects involved in the study.
References
Angelidi, Belanger, Lorinsky, Karamanis, Chamorro-Pareja et al., Vitamin D status is associated with in-hospital mortality and mechanical ventilation: A cohort of COVID-19 hospitalized patients, Mayo Clin. Proc, doi:10.1016/j.mayocp.2021.01.001
Bahat, Talma, Bestel, Selcuki, Aydın et al., Micronutrients in COVID-19 Positive Pregnancies, Cureus, doi:10.7759/cureus.10609
Bikle, Extraskeletal actions of vitamin D, Ann. N. Y. Acad. Sci, doi:10.1111/nyas.13219
Brenner, Hearing, The protective role of melanin against UV damage in human skin, Photochem. Photobiol, doi:10.1111/j.1751-1097.2007.00226.x
Caprio, Infante, Calanchini, Mammi, Fabbri et al., Not just the bone. Evidence for beneficial pleiotropic extraskeletal effects, Eat. Weight. Disord, doi:10.1007/s40519-016-0312-6
Chauss, Freiwald, Mcgregor, Yan, Wang et al., Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells, Nat. Immunol, doi:10.1038/s41590-021-01080-3
Di Mascio, Khalil, Saccone, Rizzo, Buca et al., Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1-19) during pregnancy: A systematic review and meta-analysis, AJOG MFM, doi:10.1016/j.ajogmf.2020.100107
Ferrari, Locatelli, Briguglio, Lombardi, Is there a link between vitamin D status, SARS-CoV-2 infection risk and COVID-19 severity?, Cell Biochem. Funct, doi:10.1002/cbf.3597
Gil, Plaza-Diaz, Mesa, Vitamin D: Classic and novel actions, Ann. Nutr. Metab, doi:10.1159/000486536
Katz, Yue, Xue, Increased risk for COVID-19 in patients with vitamin D deficiency, Nutrition, doi:10.1016/j.nut.2020.111106
Leino, Turpeinen, Koskinen, Automated measurement of 25-OH vitamin D3 on the Roche Modular E170 Analyzer, Clin. Chem, doi:10.1373/clinchem.2008.111732
Luo, Liao, Shen, Li, Cheng, Vitamin D deficiency is inversely associated with COVID-19 incidence and disease severity in Chinese people, J. Nutr, doi:10.1093/jn/nxaa332
Madjunkov, Dviri, Librach, A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: A Canadian perspective, J. Ovarian Res, doi:10.1186/s13048-020-00737-1
Mansur, Tajer, Mariani, Inserra, Ferder et al., Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection, Clín. Investig. Arter, doi:10.1016/j.artere.2020.11.003
Martineau, Cates, Urashima, Jensen, Griffiths et al., Vitamin D for the management to asthma, Cochrane Database Syst. Rev, doi:10.1002/14651858.CD011511.pub2
Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data, BMJ, doi:10.1136/bmj.i6583
Merzon, Tworowski, Gorohovski, Vinker, Cohen et al., Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: An Israeli population-based study, FEBS J, doi:10.1111/febs.15495
Musavi, Abazari, Barartabar, Kalaki-Jouybari, Hemmati-Dinarvand et al., The benefits of Vitamin D in the COVID-19 pandemic: Biochemical and immunological mechanisms, Arch. Physiol. Biochem, doi:10.1080/13813455.2020.1826530
Narang, Enninga, Gunaratne, Ibirogba, Trad et al., SARS-CoV-2 infection and COVID-19 during pregnancy: A multidisciplinary review, Mayo Clin. Proc, doi:10.1016/j.mayocp.2020.05.011
Norman, From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health, Am J. Clin. Nutr, doi:10.1093/ajcn/88.2.491S
Pereira, Dantas Damascena, Galvão Azevedo, De Almeida Oliveira, Da Mota Santana, Vitamin D deficiency aggravates COVID-19: Systematic review and metaanalysis, Crit. Rev. Food Sci. Nutr, doi:10.1080/10408398.2020.1841090
Pfeffer, Lu, Mann, Chen, Ho et al., Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matter, PLoS ONE, doi:10.1371/journal.pone.0200040
Qin, Lu, Yang, Xu, Luo, Does maternal vitamin D deficiency increase the risk of preterm birth: A meta-analysis of observational studies, Nutrients, doi:10.3390/nu8050301
Santamaria, Bi, Leduc, Tabatabaei, Jantchou et al., Prenatal vitamin D status and offspring's growth, adiposity and metabolic health: A systematic review and meta-analysis, Br. J. Nutr, doi:10.1017/S0007114517003646
Schulz, Cruze, Wei, Gehris, Wagner, Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy, J. Steroid Biochem. Mol. Biol, doi:10.1016/j.jsbmb.2017.02.003
Sinaci, Ocal, Yetiskin, Hendem, Buyuk et al., Impact of vitamin D on the course of COVID-19 during pregnancy: A case control study, J. Steroid Biochem. Mol. Biol, doi:10.1016/j.jsbmb.2021.105964
Smith, Kirkpatrick, Kovilam, Agrawal, Immunomodulatory role of vitamin D in the pathogenesis of preeclampsia, Expert Rev. Clin. Immunol, doi:10.1586/1744666X.2015.1056780
Tekin, Yassa, Birol, Unlu, Sahin et al., Vitamin D status is not associated with clinical severity of COVID-19 in pregnant women, Eur. J. Nutr, doi:10.1007/s00394-021-02709-7
Umar, Sastry, Chouchane, Role of vitamin D beyond the skeletal function: A review of the molecular and clinical studies, Int. J. Mol. Sci, doi:10.3390/ijms19061618
Vassiliou, Jahaj, Pratikaki, Keskinidou, Detsika et al., Vitamin D deficiency correlates with a reduced number of natural killer cells in intensive care unit (ICU) and non-ICU patients with COVID-19 pneumonia, Hell. J. Cardiol. C, doi:10.1016/j.hjc.2020.11.011
Wang, Zhang, Song, Zhang, Serum vitamin D deficiency and risk of gestational diabetes mellitus: A meta-analysis, Arch. Med. Sci, doi:10.5114/aoms.2020.94433
Wastnedge, Reynolds, Van Boeckel, Stock, Denison et al., Pregnancy and COVID-19, Physiol. Rev, doi:10.1152/physrev.00024.2020
Weishaar, Rajan, Keller, Probability of vitamin D deficiency by body weight and race/ethnicity, J. Am. Board Fam. Med, doi:10.3122/jabfm.2016.02.150251
{ 'indexed': {'date-parts': [[2022, 3, 28]], 'date-time': '2022-03-28T02:41:45Z', 'timestamp': 1648435305410}, 'reference-count': 35, 'publisher': 'MDPI AG', 'issue': '7', 'license': [ { 'start': { 'date-parts': [[2022, 3, 26]], 'date-time': '2022-03-26T00:00:00Z', 'timestamp': 1648252800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0/'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'short-container-title': ['IJERPH'], 'abstract': '<jats:p>The physiological changes during pregnancy may increase the risk of complications in ' 'pregnant women with coronavirus disease 2019 (COVID-19). Vitamin D is a fat-soluble ' 'secosteroid hormone and its role in immunity is appears to be of particular importance in ' 'this recent pandemic. Nevertheless, there is little research about the role of vitamin D ' 'levels regarding COVID-19 in pregnant women to date. This study aimed to establish a ' 'relationship between serum 25-hydroxyvitamin D (25(OH)D) levels in pregnant women and ' 'COVID-19. A comparative case-control study was performed with a study population of 256 ' 'pregnant women (82 pregnant women with infection and 174 women in control group). Serum ' '25(OH)D levels were significantly lower in pregnant women with COVID-19 infection than in ' 'those without infection. In addition, 89% of COVID-19-positive pregnant women had 25(OH)D ' 'deficiency, while in the control group the percentage was 75.30%, finding statistically ' 'significant differences (ORa = 2.68; 95% CI 1.19–6.06; p = 0.01). Our results find a ' 'relationship between vitamin D deficiency in pregnant women and COVID-19 infection. This ' 'finding could be relevant for actual clinical practice. Thus, more research is needed in this ' 'field.</jats:p>', 'DOI': '10.3390/ijerph19073965', 'type': 'journal-article', 'created': {'date-parts': [[2022, 3, 28]], 'date-time': '2022-03-28T01:27:51Z', 'timestamp': 1648430871000}, 'page': '3965', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': [ 'Serum 25(OH) Vitamin D Levels in Pregnant Women with Coronavirus Disease 2019 (COVID-19): A ' 'Case-Control Study'], 'prefix': '10.3390', 'volume': '19', 'author': [ {'given': 'Nazaret', 'family': 'Ferrer-Sánchez', 'sequence': 'first', 'affiliation': []}, {'given': 'Marina', 'family': 'Díaz-Goicoechea', 'sequence': 'additional', 'affiliation': []}, {'given': 'Victoria', 'family': 'Mayoral-Cesar', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-9043-7745', 'authenticated-orcid': False, 'given': 'Silvia', 'family': 'García-Solbas', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-5917-7404', 'authenticated-orcid': False, 'given': 'Bruno José', 'family': 'Nievas-Soriano', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tesifón', 'family': 'Parrón-Carreño', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-4844-2145', 'authenticated-orcid': False, 'given': 'Ana María', 'family': 'Fernández-Alonso', 'sequence': 'additional', 'affiliation': []}], 'member': '1968', 'published-online': {'date-parts': [[2022, 3, 26]]}, 'reference': [ {'key': 'ref1', 'unstructured': 'Coronavirus (COVID-19)https://who.sprinklr.com/'}, {'key': 'ref2', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s13048-020-00737-1'}, {'key': 'ref3', 'doi-asserted-by': 'publisher', 'DOI': '10.1152/physrev.00024.2020'}, {'key': 'ref4', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ajogmf.2020.100107'}, {'key': 'ref5', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.mayocp.2020.05.011'}, {'key': 'ref6', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/ajcn/88.2.491S'}, {'key': 'ref7', 'doi-asserted-by': 'publisher', 'DOI': '10.1159/000486536'}, {'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/nyas.13219'}, {'key': 'ref9', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ijms19061618'}, {'key': 'ref10', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s40519-016-0312-6'}, {'key': 'ref11', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.i6583'}, {'key': 'ref12', 'doi-asserted-by': 'publisher', 'DOI': '10.1586/1744666X.2015.1056780'}, {'key': 'ref13', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jsbmb.2017.02.003'}, {'key': 'ref14', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu8050301'}, {'key': 'ref15', 'doi-asserted-by': 'publisher', 'DOI': '10.5114/aoms.2020.94433'}, {'key': 'ref16', 'doi-asserted-by': 'publisher', 'DOI': '10.1017/S0007114517003646'}, {'key': 'ref17', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/j.1751-1097.2007.00226.x'}, {'key': 'ref18', 'doi-asserted-by': 'publisher', 'DOI': '10.3122/jabfm.2016.02.150251'}, { 'key': 'ref19', 'unstructured': 'Living Guidance for Clinical Management of ' 'COVID-19https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2'}, {'key': 'ref20', 'doi-asserted-by': 'publisher', 'DOI': '10.1373/clinchem.2008.111732'}, {'key': 'ref21', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jsbmb.2021.105964'}, {'key': 'ref22', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00394-021-02709-7'}, {'key': 'ref23', 'doi-asserted-by': 'publisher', 'DOI': '10.7759/cureus.10609'}, {'key': 'ref24', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/febs.15495'}, {'key': 'ref25', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.nut.2020.111106'}, {'key': 'ref26', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/10408398.2020.1841090'}, {'key': 'ref27', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/jn/nxaa332'}, {'key': 'ref28', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.mayocp.2021.01.001'}, {'key': 'ref29', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/14651858.CD011511.pub2'}, {'key': 'ref30', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0200040'}, {'key': 'ref31', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/13813455.2020.1826530'}, {'key': 'ref32', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.artere.2020.11.003'}, {'key': 'ref33', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/cbf.3597'}, {'key': 'ref34', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41590-021-01080-3'}, {'key': 'ref35', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.hjc.2020.11.011'}], 'container-title': ['International Journal of Environmental Research and Public Health'], 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.mdpi.com/1660-4601/19/7/3965/pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 3, 28]], 'date-time': '2022-03-28T01:59:06Z', 'timestamp': 1648432746000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.mdpi.com/1660-4601/19/7/3965'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 3, 26]]}, 'references-count': 35, 'journal-issue': {'issue': '7', 'published-online': {'date-parts': [[2022, 4]]}}, 'alternative-id': ['ijerph19073965'], 'URL': 'http://dx.doi.org/10.3390/ijerph19073965', 'relation': {}, 'ISSN': ['1660-4601'], 'issn-type': [{'value': '1660-4601', 'type': 'electronic'}], 'subject': ['Health, Toxicology and Mutagenesis', 'Public Health, Environmental and Occupational Health'], 'published': {'date-parts': [[2022, 3, 26]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit